ProQR Therapeutics NV (PRQR)
3.96
-0.02
(-0.50%)
USD |
NASDAQ |
Nov 14, 12:24
ProQR Therapeutics Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Free Cash Flow Data
| Date | Value |
|---|---|
| March 28, 2024 | -- |
| March 27, 2024 | -- |
| March 26, 2024 | -- |
| March 25, 2024 | -- |
| March 22, 2024 | -- |
| March 21, 2024 | -- |
| March 20, 2024 | -- |
| March 19, 2024 | -- |
| March 18, 2024 | -- |
| March 15, 2024 | -- |
| March 14, 2024 | -- |
| March 13, 2024 | -- |
| March 12, 2024 | -- |
| March 11, 2024 | -- |
| March 08, 2024 | -- |
| March 07, 2024 | -- |
| March 06, 2024 | -- |
| March 05, 2024 | -- |
| March 04, 2024 | -- |
| March 01, 2024 | -- |
| February 29, 2024 | -- |
| February 28, 2024 | -- |
| February 27, 2024 | -- |
| February 26, 2024 | -- |
| February 23, 2024 | -- |
| Date | Value |
|---|---|
| February 22, 2024 | -- |
| February 21, 2024 | -- |
| February 20, 2024 | -- |
| February 16, 2024 | -- |
| February 15, 2024 | -- |
| February 14, 2024 | -- |
| February 13, 2024 | -- |
| February 12, 2024 | -- |
| February 09, 2024 | -- |
| February 08, 2024 | -- |
| February 07, 2024 | -- |
| February 06, 2024 | -- |
| February 05, 2024 | -- |
| February 02, 2024 | -- |
| February 01, 2024 | -- |
| January 31, 2024 | -- |
| January 30, 2024 | -- |
| January 29, 2024 | -- |
| January 26, 2024 | -- |
| January 25, 2024 | -- |
| January 24, 2024 | -- |
| January 23, 2024 | -- |
| January 22, 2024 | -- |
| January 19, 2024 | -- |
| January 18, 2024 | -- |
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.
Price to Free Cash Flow Range, Past 5 Years
Price to Free Cash Flow Benchmarks
| uniQure NV | -- |
| Merus NV | -- |
| argenx SE | -- |
| Pharming Group | -- |
| Pharvaris NV | -- |